Macleods Pharmaceutical Limited
|Mefenamic Acid||250 mg|
|Tranexamic Acid||500 mg|
Click on the API name to know their properties
|Composit uses/ indication of TRAPIC MF :|
Dysmenorrhoea, Fever, Inflammation, Juvenile chronic arthritis, Menorrhagia, Migraine, Musculoskeletal disorders, Osteoarthritis, Pain, Post-operative pain, Post-partum pain, Rheumatoid arthritis, Symptomatic relief of GI-disorders, Toothache, Traumatic pain.
Acute spasm and spasm in diagnostic procedures, Angioneurotic edema, Haemophilia, Prevention of bleeding, Subarachnoid haemorrhage, Epistaxis, GI hemorrhage, Menorrhagia.
|Composit contra indication of TRAPIC MF :|
Hypersensitivity, epilepsy, Pregnancy and lactation, Inflammatory bowel disease, peptic ulcer, neonates. Coronary artery bypass graft surgery, severe renal impairment, severe heart failure.
Severe renal failure, active intravascular clotting, thromboembolic disease, colour vision disorders, subarachnoid bleeding.
|Composit side effects of TRAPIC MF :|
Headaches, Nervousness and Vomiting, Diarrhea, Hematemesis (vomiting blood), Haematuria (blood in urine), Blurred Vision, Skin Rash, Itching and Swelling, Sore Throat and Fever.
Diarrhea, nausea, vomiting. Headache, migraine, giddiness, fatigue. Low blood pressure. Impaired vision or disturbances in color vision. Joint pain, back pain, muscle pain. Blot clot events.
|Composit caution of TRAPIC MF :|
Renal and hepatic impairment, asthma. Monitor blood counts and liver function during long-term therapy. Drowsiness may affect ability to perform skilled tasks. Elderly.
Irregular menstrual bleeding, previous history of thromboembolic disease, haematuria. Monitor closely in disseminated intravascular coagulation. Monitor LFT and eye examination regularly during long-term use. Discontinue if disturbance in colour vision occurs. Avoid IV inj rate >1 ml/minute due to risk of hypotension. Pregnancy, lactation.